US drugmaker Bristol Myers Squibb buys Mirati for $4.8bn, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Bristol Myers Squibb will pay $58 per share in cash “for a total equity value of $4.8 billion,” the companies said in a joint statement. In addition, a guaranteed value certificate (GVC) could provide Mirati shareholders with a potential additional $12.00 per share, or up to an additional $1 billion in total., Bristol Myers Squibb will pay $58 per share in cash “for a total equity value of $4.8 billion,” the companies said in a joint statement. In addition, a guaranteed value certificate (GVC) could provide Mirati shareholders with a potential additional $12.00 per share, or up to an additional $1 billion in total., , Read More